PD-LI or PD-L2 in tumor cells and CD80/86, which inhibits CTLA-4 and antigen-presenting cells, combine to maintain T cell activity, which can be divided into three types: PD-1, PD-L1, and CTLA-4. The gene discussed is CD274; the disease is neoplasm.